Mesoblast (MSB) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MSB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Heres what $1k invested in Mesoblast shares a month ago is worth nowAugust 14, 2025 | msn.comHealth Check: Biotechs rush to short-term funding fixAugust 11, 2025 | msn.comLunch Wrap: ASX smashes 8700 for first time as BHP crushes records, Mesoblast soarsJuly 18, 2025 | msn.comMesoblast Limited: Successful Commercial Launch of RyoncilJuly 18, 2025 | finanznachrichten.deMesoblast Shares Jump Premarket on Early Revenue From Commercial Launch of RyoncilJuly 18, 2025 | marketwatch.comThe Mesoblast share price just rocketed 38%! Here's whyJuly 18, 2025 | msn.comMesoblast shares soar 35pc on strong cell therapy sales dataJuly 18, 2025 | afr.comWhy is the Mesoblast share price up 11% in June?June 17, 2025 | msn.comDr Boreham’s Crucible: Can this biotech emerge from Mesoblast’s shadow and ride ‘stem cells 2.0’?May 19, 2025 | msn.comDr Boreham’s Crucible: Can this biotech emerge from Mesoblast’s shadow and ride ‘stem cells 2.0’?May 19, 2025 | msn.comBroker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX sharesApril 5, 2025 | msn.comFriday's HotCopper Trends: Mesoblast dodges tariffs, Orthocell's FDA tick | April 4, 2025April 4, 2025 | msn.comMesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean labApril 4, 2025 | msn.comMesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. TariffsApril 3, 2025 | markets.businessinsider.comMesoblast Limited: First Three Children to Commence Treatment With RyoncilMarch 31, 2025 | finanznachrichten.deThursday's HotCopper Trends: Mesoblast bags FDA tick, Hot Chili extends mine life | March 27, 2025March 27, 2025 | msn.comMesoblast kicks off Ryoncil sales in US but shareholders eager for revenueMarch 27, 2025 | msn.comWhy Mesoblast shares could still be dirt cheap even after 700% gainMarch 5, 2025 | msn.comMesoblast share price rips 12% on financial and operational updatesFebruary 26, 2025 | msn.comMesoblast Limited: Mesoblast Financial Results and Corporate Update WebcastFebruary 26, 2025 | finanznachrichten.deRyoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsFebruary 13, 2025 | finance.yahoo.comBullish Mesoblast Insiders Loaded Up On US$145.4m Of StockJanuary 24, 2025 | finance.yahoo.comWhy is the Mesoblast share price crashing 9% today?January 13, 2025 | msn.comMesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- UpdateDecember 19, 2024 | marketwatch.comMesoblast Finally Gets Its Approval In GVHD: Where Now?December 19, 2024 | seekingalpha.comMesoblast shares rocket on FDA approval, but CEO says risks remainDecember 19, 2024 | afr.comFDA Approves Mesoblast's Cell Therapy To Treat Steroid-refractory Acute Graft-versus-host DiseaseDecember 18, 2024 | markets.businessinsider.com3 ASX 300 shares smashing new highs while the market divesDecember 18, 2024 | fool.com.auMesoblast ADRs Rise 22%, Company Joining Nasdaq Biotechnology IndexDecember 18, 2024 | marketwatch.comMesoblast share price rockets 30% on big US FDA newsDecember 18, 2024 | msn.comJPMorgan Chase Ceases Substantial Holding in MesoblastDecember 17, 2024 | markets.businessinsider.comFDA Grants RMAT Designation To Mesoblast's Revascor For Pediatric Hypoplastic Left Heart SyndromeDecember 5, 2024 | markets.businessinsider.comWhat on Earth is happening with Mesoblast shares today?December 5, 2024 | fool.com.auChartWatch ASX Scans: Aristocrat Leisure, Bravura Solutions, Mesoblast, MTM Critical Metals, Pro Medicus, Qantas, Syntara, WorleyDecember 3, 2024 | msn.comMesoblast Limited's (ASX:MSB) 17% gain last week benefited both retail investors who own 54% as well as insidersNovember 29, 2024 | finance.yahoo.comJPMorgan Chase Takes Significant Stake in MesoblastNovember 21, 2024 | markets.businessinsider.com3 ASX healthcare shares going gangbusters on ThursdayNovember 15, 2024 | msn.comUp 427% this year, why today is a big day for Mesoblast sharesNovember 14, 2024 | msn.comAustralia shares higher at close of trade; S&P/ASX 200 up 0.37%November 14, 2024 | msn.comMesoblast Limited Issues Unquoted Warrants in Strategic MoveNovember 12, 2024 | msn.comAustralia shares lower at close of trade; S&P/ASX 200 down 0.12%October 24, 2024 | msn.com3 High Growth Tech Stocks in Australia to WatchOctober 8, 2024 | uk.finance.yahoo.comAustralia shares lower at close of trade; S&P/ASX 200 down 0.67%October 4, 2024 | msn.com2 ASX healthcare shares rocketing over 16% on Big US newsOctober 3, 2024 | fool.com.auCashed up & ready to go: Mesoblast forges funding deal with top shareholderSeptember 30, 2024 | msn.comIf you'd invested $6,000 in the ASX 300 stock in January, you'd have $22,551 today!September 27, 2024 | msn.comEvening Wrap: ASX 200 notches an important record as broad-based gain sees us bid farewell to another earnings seasonAugust 30, 2024 | msn.comMesoblast Full Year 2024 Earnings: Misses ExpectationsAugust 30, 2024 | finance.yahoo.comBell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF)August 30, 2024 | markets.businessinsider.comBrazil finance chief says he suggested new cenbank head be picked by SeptemberAugust 28, 2024 | ca.finance.yahoo.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MSB and its competitors with MarketBeat's FREE daily newsletter. Email Address MSB Media Mentions By Week MSB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MSB News Sentiment▼0.950.66▲Average Medical News Sentiment MSB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MSB Articles This Week▼11▲MSB Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GLXY News Today REXR News Today HLNE News Today BRX News Today PSLV News Today BULL News Today AC News Today STEP News Today JHG News Today CEF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:MSB) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access